Mast cell activation may contribute to adverse health transitions in COVID-19 patients with frailty.

Li, Xiangqi; Zhang, Chaobao; Bao, Zhijun

Li, Xiangqi; Zhang, Chaobao; Bao, Zhijun.

Afiliação

Li X; Department of Endocrinology and Metabolism, Gongli Hospital, Naval Medical University, Shanghai, People's Republic of China.
Zhang C; Shanghai Key Laboratory of Clinical Geriatric Medicine; Department of Geriatric Medicine, Huadong Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Bao Z; Shanghai Key Laboratory of Clinical Geriatric Medicine; Department of Geriatric Medicine, Huadong Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

Emerg Microbes Infect ; 12(2): 2251589, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37606034

Assuntos

COVID-19; Fragilidade; Humanos; Pessoa de Meia-Idade; Síndrome de COVID-19 Pós-Aguda; Transição Epidemiológica; Mastócitos

Palavras-chave

Long-COVID; etiology; frailty; mast cell; transitions

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragilidade / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans / Middle aged Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google